SOCS3 and breast cancer: miR-9 and miR-181a facilitates the development and immunosuppressive function of e-MDSCs through the interference with suppressor of cytokine signaling 3 (SOCS3) and protein inhibitor of activated STAT3 (PIAS3), separately, thus leading to immune escape and tumor growth in breast cancer (54).